Study on the influence of metformin on castration-resistant prostate cancer PC-3 cell line biological behavior by its inhibition on PLCε gene-mediated Notch1/Hes and androgen receptor signaling pathway
- PMID: 28485785
Study on the influence of metformin on castration-resistant prostate cancer PC-3 cell line biological behavior by its inhibition on PLCε gene-mediated Notch1/Hes and androgen receptor signaling pathway
Abstract
Objective: To study the regulation of metformin on the biological behaviors of the castration-resistant prostate cancer (CRPC) PC-3 cell such as proliferation, invasion, apoptosis through influencing Notch1/Hes and androgen receptor (AR) signaling pathway activity by its inhibition on the expression of PLCε gene.
Materials and methods: Human prostate cancer-3 (PC-3) cell line was divided into PC-3 cell line (group A), PC-3 cell line + metformin (10 mM) (group B), PC-3 cell line + metformin (20 mM) (group C), PLCε gene knockout cell line (group D), PLCε knockout cell line + metformin (10 mM)_ (group E) and PLCε knockout cell line + metformin (20 mM) (group F), which were respectively tested at 24 h, 48 h and 72 h, and five duplicate wells were set at each time point in each group. Western blot assay and RT-PCR assay were used to test the relative expressions of PLCε, Notch1, Hes, AR protein and mRNA; MTT assay was used to test the cell proliferation. Transwell chamber was used to test the invasion capability. The scratch test was used to test the migration capability and the flow cytometer was used to test cell apoptosis.
Results: The relative expressions of PLCε, Notch1, Hes, AR protein and mRNA in Group A were increased gradually with time, but those values in group B and group C were decreased gradually with time and also significantly lower than those in group A (p <0.05) at each time point. The relative expressions of PLCε, Notch1, Hes, AR protein and mRNA in-group D, group E and group F were not changed at each time point (p>0.05). The proliferation, invasion and migration capabilities of the cells in group A, group D, group E and group F were gradually increased with time, but those in group B and group C were rapidly decreased with time and also significantly lower than those in group A, group D, group E and group F (p<0.05) at each time point. The apoptosis rates of group B and group C were increased gradually with time, and there was no other significant change in each group (p<0.05).
Conclusions: Metformin can regulate the biological behaviors of CRPC PC-3 cell line such as proliferation, invasion, migration and apoptosis through influencing Notch1/Hes and AR signaling pathway activity by its inhibition on the expression of PLCε gene.
Similar articles
-
PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor.Cancer Lett. 2015 Jun 28;362(1):61-9. doi: 10.1016/j.canlet.2015.03.018. Epub 2015 Mar 18. Cancer Lett. 2015. PMID: 25796442
-
Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.Oncol Rep. 2019 May;41(5):2689-2702. doi: 10.3892/or.2019.7054. Epub 2019 Mar 7. Oncol Rep. 2019. PMID: 30864728 Free PMC article.
-
Metformin mitigates PLCε gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration-resistant prostate cancer xenograft models.Oncol Lett. 2021 Oct;22(4):715. doi: 10.3892/ol.2021.12976. Epub 2021 Aug 8. Oncol Lett. 2021. Retraction in: Oncol Lett. 2025 May 12;30(1):336. doi: 10.3892/ol.2025.15082. PMID: 34429755 Free PMC article. Retracted.
-
PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis.Oncol Rep. 2020 May;43(5):1397-1412. doi: 10.3892/or.2020.7520. Epub 2020 Feb 26. Oncol Rep. 2020. PMID: 32323799 Free PMC article.
-
Activation of the Notch1 Stem Cell Signaling Pathway during Routine Cell Line Subculture.Front Oncol. 2014 Aug 6;4:211. doi: 10.3389/fonc.2014.00211. eCollection 2014. Front Oncol. 2014. PMID: 25147757 Free PMC article. Review. No abstract available.
Cited by
-
Autophagy-induced degradation of Notch1, achieved through intermittent fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes.Open Heart. 2019 May 22;6(1):e001028. doi: 10.1136/openhrt-2019-001028. eCollection 2019. Open Heart. 2019. PMID: 31218007 Free PMC article. No abstract available.
-
PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.J Exp Clin Cancer Res. 2019 Aug 5;38(1):337. doi: 10.1186/s13046-019-1323-8. J Exp Clin Cancer Res. 2019. PMID: 31383001 Free PMC article.
-
Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses.Transl Oncol. 2021 Nov;14(11):101209. doi: 10.1016/j.tranon.2021.101209. Epub 2021 Aug 31. Transl Oncol. 2021. PMID: 34479029 Free PMC article.
-
Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway.Oncol Lett. 2019 May;17(5):4277-4284. doi: 10.3892/ol.2019.10119. Epub 2019 Mar 6. Oncol Lett. 2019. PMID: 30944622 Free PMC article.
-
Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole.Oncol Lett. 2019 Aug;18(2):1697-1712. doi: 10.3892/ol.2019.10509. Epub 2019 Jun 21. Oncol Lett. 2019. PMID: 31423237 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials